MORRISVILLE N.C.--(BUSINESS WIRE)--Sicel Technologies, Inc., a leading developer and manufacturer of implantable sensors and surface dosimeters, announced that Dr. Charles Scarantino, its founder, chairman and medical director, has been elected a Fellow of the American Society for Therapeutic Radiology and Oncology (ASTRO). Dr. Scarantino received his FASTRO designation on November 5 at a special ceremony during ASTRO’s 48th Annual Meeting in Philadelphia. The Company also announced that it had closed on an offering of convertible bonds. Burton Advisers Ltd. acted as advisor to the Company in this placement.
